Stock Scorecard
Stock Summary for CVRx Inc (CVRX) - $14.29 as of 4/24/2024 3:37:48 PM EST
Total Score
9 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for CVRX
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for CVRX
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for CVRX
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for CVRX
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for CVRX
Financial Details for CVRX
Company Overview |
|
---|---|
Ticker | CVRX |
Company Name | CVRx Inc |
Country | USA |
Description | CVRx, Inc. develops implantable technology for the treatment of patients with high blood pressure / hypertension and heart failure. |
Sector Name | LIFE SCIENCES |
Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 4/25/2024 |
Stock Price History |
|
Last Day Price | 14.29 |
Last Day Price Updated | 4/24/2024 3:37:48 PM EST |
Last Day Volume | 0 |
Average Daily Volume | 116,915 |
52-Week High | 33.13 |
52-Week Low | 9.27 |
Last Price to 52 Week Low | 54.15% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | 47.46 |
Sector PE | 60.54 |
5-Year Average PE | -6.30 |
Free Cash Flow Ratio | 3.30 |
Industry Free Cash Flow Ratio | 61.03 |
Sector Free Cash Flow Ratio | 30.19 |
Current Ratio Most Recent Quarter | 14.25 |
Total Cash Per Share | 4.33 |
Book Value Per Share Most Recent Quarter | 3.64 |
Price to Book Ratio | 4.75 |
Industry Price to Book Ratio | 5.21 |
Sector Price to Book Ratio | 22.08 |
Price to Sales Ratio Twelve Trailing Months | 9.18 |
Industry Price to Sales Ratio Twelve Trailing Months | 14.23 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.16 |
Share Statistics |
|
Total Shares Outstanding | 20,927,700 |
Market Capitalization | 299,056,833 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | 0.55% |
Reported EPS 12 Trailing Months | -1.99 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | -1.98 |
Net Income Twelve Trailing Months | -41,199,000 |
Net Income Past Year | -41,199,000 |
Net Income Prior Year | -41,428,000 |
Quarterly Revenue Growth YOY | 57.50% |
5-Year Revenue Growth | 73.62% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 90,569,000 |
Total Cash Past Year | 90,569,000 |
Total Cash Prior Year | 106,194,000 |
Net Cash Position Most Recent Quarter | 31,347,000 |
Net Cash Position Past Year | 31,347,000 |
Long Term Debt Past Year | 59,222,000 |
Long Term Debt Prior Year | 6,747,000 |
Total Debt Most Recent Quarter | 59,222,000 |
Equity to Debt Ratio Past Year | 0.56 |
Equity to Debt Ratio Most Recent Quarter | 0.56 |
Total Stockholder Equity Past Year | 75,947,000 |
Total Stockholder Equity Prior Year | 109,180,000 |
Total Stockholder Equity Most Recent Quarter | 75,947,000 |
Options |
|
Put/Call Ratio | 0.00 |
Has Options | Options Chain |
Liquidity Rating | None |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -1.30 |
MACD Signal | -1.12 |
20-Day Bollinger Lower Band | 13.46 |
20-Day Bollinger Middle Band | 22.57 |
20-Day Bollinger Upper Band | 31.67 |
Beta | 1.23 |
RSI | 25.07 |
50-Day SMA | 18.57 |
200-Day SMA | 0.00 |
System |
|
Modified | 4/24/2024 10:20:04 PM EST |